Shen H, Dang W, Su R, Zhang Z, et al. Pretreatment lymphocyte-monocyte ratio (LMR) as a superior predictor of short-term progression outcomes in patients with gastric cancer receiving second- and later-line apatinib regimens. J Cancer Res Clin Oncol 2023 Jun 12. doi: 10.1007/s00432-023-04976.
PMID: 37308747